321 related articles for article (PubMed ID: 30612604)
1. Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases.
Maniscalco M; Fuschillo S; Paris D; Cutignano A; Sanduzzi A; Motta A
Adv Clin Chem; 2019; 88():121-149. PubMed ID: 30612604
[TBL] [Abstract][Full Text] [Related]
2. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.
Nobakht M Gh BF; Aliannejad R; Rezaei-Tavirani M; Taheri S; Oskouie AA
Biomarkers; 2015 Feb; 20(1):5-16. PubMed ID: 25403491
[TBL] [Abstract][Full Text] [Related]
3. Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease.
Santini G; Mores N; Penas A; Capuano R; Mondino C; Trové A; Macagno F; Zini G; Cattani P; Martinelli E; Motta A; Macis G; Ciabattoni G; Montuschi P
Curr Top Med Chem; 2016; 16(14):1610-30. PubMed ID: 26693732
[TBL] [Abstract][Full Text] [Related]
4. Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate.
Sofia M; Maniscalco M; de Laurentiis G; Paris D; Melck D; Motta A
J Biomed Biotechnol; 2011; 2011():403260. PubMed ID: 21437214
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.
Zang X; Pérez JJ; Jones CM; Monge ME; McCarty NA; Stecenko AA; Fernández FM
J Am Soc Mass Spectrom; 2017 Aug; 28(8):1489-1496. PubMed ID: 28364225
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study.
Maniscalco M; Paris D; Melck DJ; Molino A; Carone M; Ruggeri P; Caramori G; Motta A
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29348154
[No Abstract] [Full Text] [Related]
7. Exhaled breath condensate biomarkers in COPD.
Borrill ZL; Roy K; Singh D
Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
[TBL] [Abstract][Full Text] [Related]
8. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy.
de Laurentiis G; Paris D; Melck D; Maniscalco M; Marsico S; Corso G; Motta A; Sofia M
Eur Respir J; 2008 Nov; 32(5):1175-83. PubMed ID: 18653649
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of some pulmonary diseases in exhaled breath.
Kharitonov SA; Barnes PJ
Biomarkers; 2002; 7(1):1-32. PubMed ID: 12101782
[TBL] [Abstract][Full Text] [Related]
10. Exhaled biomarkers.
Kharitonov SA; Barnes PJ
Chest; 2006 Nov; 130(5):1541-6. PubMed ID: 17099035
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics of Exhaled Breath Condensate by Nuclear Magnetic Resonance Spectroscopy and Mass Spectrometry: A Methodological Approach.
Maniscalco M; Cutignano A; Paris D; Melck DJ; Molino A; Fuschillo S; Motta A
Curr Med Chem; 2020; 27(14):2381-2399. PubMed ID: 30295185
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in exhaled breath condensate as fingerprints of asthma, chronic obstructive pulmonary disease and asthma-chronic obstructive pulmonary disease overlap: a critical review.
Seyfinejad B; Nemutlu E; Taghizadieh A; Khoubnasabjafari M; Ozkan SA; Jouyban A
Biomark Med; 2023 Oct; 17(19):811-837. PubMed ID: 38179966
[TBL] [Abstract][Full Text] [Related]
13. Application of metabolomics approaches to the study of respiratory diseases.
Snowden S; Dahlén SE; Wheelock CE
Bioanalysis; 2012 Sep; 4(18):2265-90. PubMed ID: 23046268
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis.
Esther CR; Boysen G; Olsen BM; Collins LB; Ghio AJ; Swenberg JW; Boucher RC
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L987-93. PubMed ID: 19304910
[TBL] [Abstract][Full Text] [Related]
15. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures.
Motta A; Paris D; D'Amato M; Melck D; Calabrese C; Vitale C; Stanziola AA; Corso G; Sofia M; Maniscalco M
J Proteome Res; 2014 Dec; 13(12):6107-20. PubMed ID: 25393672
[TBL] [Abstract][Full Text] [Related]
16. Is NMR-based metabolomic analysis of exhaled breath condensate accurate?
Izquierdo-García JL; Peces-Barba G; Heili S; Diaz R; Want E; Ruiz-Cabello J
Eur Respir J; 2011 Feb; 37(2):468-70. PubMed ID: 21282813
[No Abstract] [Full Text] [Related]
17. Feasibility of Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics: A Pilot Study.
Zang X; Monge ME; McCarty NA; Stecenko AA; Fernández FM
J Proteome Res; 2017 Feb; 16(2):550-558. PubMed ID: 28152602
[TBL] [Abstract][Full Text] [Related]
18. [The pH of the exhaled breath condensate: new method for investigation of inflammatory airway diseases].
Szili B; Bikov A; Kollai M; Horváth I
Orv Hetil; 2007 Jul; 148(26):1217-24. PubMed ID: 17588855
[TBL] [Abstract][Full Text] [Related]
19. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases.
Carpagnano GE; Lacedonia D; Carone M; Soccio P; Cotugno G; Palmiotti GA; Scioscia G; Foschino Barbaro MP
J Breath Res; 2016 Apr; 10(2):026005. PubMed ID: 27063576
[TBL] [Abstract][Full Text] [Related]
20. [Exhaled breath condensate and its analysis--a new method in pulmonology].
Vass G; Huszár E; Barát E; Horváth I
Orv Hetil; 2003 Dec; 144(51):2517-24. PubMed ID: 14974158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
